Cancer Treatment
Researchers' work from Canada and Switzerland adds to cancer treatment body of knowledge
Published in Women's Health Weekly, August 3rd, 2006
Study 1: Antiangiogenic therapy sustains tumor hypoxia but impairs vascular development.
"Because antiangiogenic therapies inhibit the growth of new tumor-associated blood vessels, as well as prime newly formed vasculature, they would be expected to reduce the supply of oxygen and thus increase tumor hypoxia. However, it is not clear if antiangiogenic treatments lead only to consistent and sustained increases in hypoxia, or transient decreases in tumor hypoxia along with periods of increased hypoxia," researchers in Canada report.
"We undertook a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Back Pain
Chronic low back pain may be related to increased estrogen levels in women - Breast Cancer
Older women may exhibit cognitive function loss in conjunction with adjuvant chemotherapy - Cardiology
Peak oxygen consumption may not be as predictive in women for timing of cardiac transplant - Sexual & Reproductive Health
Polycystic ovary morphology in women with type 1 diabetes may be related to insulin therapy - Type 2 Diabetes
Risk of type 2 diabetes is increased in women with high dietary iron intake - Adverse Drug Reaction
Lamotrigine use during pregnancy linked to increased risk of cleft palate/cleft lip - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
